Directors' Report: Governance - British American Tobacco
Directors' Report: Governance - British American Tobacco
Directors' Report: Governance - British American Tobacco
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
www.bat.com/annualreport2009<br />
Key activities of the Nominations Committee in 2009<br />
The Nominations Committee met five times in 2009. The specific<br />
items considered by it included:<br />
■ the recruitment of Dr Gerry Murphy and his appointment<br />
to the Board as a Non-Executive Director;<br />
■ the announcement by Jan du Plessis of his intention to take<br />
up the role of Chairman of Rio Tinto p.l.c;<br />
■ an updated role profile identifying the skills required for the<br />
role of Chairman;<br />
■ the recruitment and appointment to the Board as a Non-<br />
Executive Director of Richard Burrows and his subsequent<br />
appointment as Chairman on Jan du Plessis’ retirement;<br />
■ continuing measures to refresh the Board, including further<br />
non-executive appointments;<br />
■ succession planning for the Executive Directors and members<br />
of the Management Board; and<br />
■ changes in the composition of the Management Board.<br />
In 2009, the Committee reviewed its effectiveness as part of the Board<br />
evaluation process. It concluded that it continues to operate effectively<br />
and, in particular, that early discussions around succession planning<br />
have helped by setting the context before decisions on timing and<br />
candidates are required. The Committee identified a need for<br />
additional non-executive appointments.<br />
Terms of appointment to the Board<br />
The Executive Directors have rolling contracts of one year. The Non-<br />
Executive Directors do not have service contracts with the Company<br />
but instead have letters of appointment. Details of the Company’s<br />
policy on Executive Directors’ service contracts and the terms of<br />
appointment for Non-Executive Directors are set out in the<br />
Remuneration report.<br />
Directors’ interests and indemnities<br />
Further details of Directors’ contracts and letters of appointment,<br />
remuneration and emoluments, and their interests in the shares of the<br />
Company (including interests in share options and deferred shares)<br />
as at 31 December 2009 are given in the Remuneration report. No<br />
Director had any material interest in a contract of significance (other<br />
than a service contract) with the Company or any subsidiary company<br />
during the year.<br />
Prior to his appointment as a Non-Executive Director, and subsequently<br />
as Chairman, Richard Burrows disclosed to the Board that he is a<br />
director of Rentokil Initial plc. Although this gives rise to no current<br />
conflict of interest, the potential situational conflict was reviewed by<br />
the Board and approved in accordance with the Company’s Articles<br />
of Association.<br />
Directors’ report: <strong>Governance</strong><br />
The Company’s practice has always been to indemnify its Directors<br />
in accordance with the Company’s Articles of Association and to<br />
the maximum extent permitted by law. As at the date of this report,<br />
such indemnities are in force covering any costs, charges, expenses or<br />
liabilities which they may incur in or about the execution of their duties<br />
to the Company or to any entity which is an associated company (as<br />
defined in Section 256 of the Companies Act 2006), or as a result of<br />
duties performed by the Directors on behalf of the Company or any<br />
such associated company.<br />
Retirement by rotation and reappointment<br />
Directors are submitted for reappointment at regular intervals by<br />
application of the Company’s Articles of Association. These require that<br />
at each Annual General Meeting, all Directors shall retire from office<br />
by rotation who held office at the time of each of the two preceding<br />
Annual General Meetings and who (at either of those preceding Annual<br />
General Meetings): (1) did not previously retire by rotation, or (2) were<br />
reappointed following his/her appointment as an additional Director<br />
or to fill a vacancy. If the number of Directors retiring in this way is<br />
less than one-third of the Directors who are subject to retirement by<br />
rotation or if their number is not three or a multiple of three, then<br />
additional Directors shall retire by rotation provided that a number not<br />
exceeding one-third shall retire from office. Subject to the provisions of<br />
the Companies Act 2006 and the Articles of Association, the Directors<br />
to retire by rotation will be those who have been in office the longest<br />
since their appointment or last reappointment.<br />
The Board has progressively refreshed its membership over a number<br />
of years. In this context, Non-Executive Directors who serve for a total<br />
of more than six years are subject to a particularly rigorous review, and<br />
additional service after that time is reviewed annually. This was done in<br />
the case of Ana Maria Llopis, given that she has been a Non-Executive<br />
Director since February 2003.<br />
In accordance with the Articles of Association, and further to<br />
recommendations made by the Nominations Committee to the<br />
Board, the Directors named below will retire from the Board at the<br />
forthcoming Annual General Meeting and, being eligible, will offer<br />
themselves for reappointment:<br />
Ana Maria Llopis<br />
Christine Morin-Postel<br />
Anthony Ruys<br />
<strong>British</strong> <strong>American</strong> <strong>Tobacco</strong> Annual <strong>Report</strong> 2009<br />
In addition, Richard Burrows, having been appointed as a Director on<br />
1 September 2009, will also retire from the Board at the forthcoming<br />
Annual General Meeting and, being eligible, will offer himself for<br />
reappointment.<br />
77<br />
From the Chairman<br />
Performance<br />
and strategy Regional review Financial review <strong>Governance</strong><br />
Group financial<br />
statements<br />
Parent Company<br />
financial statements<br />
Shareholder<br />
information